Back in August, I reported how Pfizer hurriedly cut short the clinical trial for its COVID-19 mRNA 'vaccine', variously known as "Comirnaty" and "BNT162b2". The supposedly double-blind trial originally had an Estimated Primary Completion Date of 11 August 2021 and a Study Completion Date of 23 March 2023.